Health care industry
Athenahealth to offer Abridge’s AI scribe to its network of thousands of doctors
A doctor looks at an AI-generated clinical note. Courtesy of Athenahealth Health-care software vendor Athenahealth on Tuesday said it will offer Abridge’s artificial intelligence scribing tool to its network of more than 160,000 clinicians. Athenahealth has developed an electronic health record, revenue cycle management tools and patient engagement tools for ambulatory care providers, which include […]
Read More
Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters Eli Lilly on Tuesday released higher doses of its weight loss drug Zepbound in single-dose vials at as much as half its usual monthly list price to reach more patients without […]
Read More
Hims & Hers shares tumble 18% as margin miss adds to concerns about GLP-1 business
The New York Stock Exchange with a Hims & Hers Health banner is pictured in the Manhattan borough of New York City. Carlo Allegri | Reuters Hims & Hers Health shares plunged 18% in extended trading on Monday after investors looked past better-than-expected revenue and earnings and focused instead on the disappointing gross margin. Here’s […]
Read More
Chinese medical devices are in health systems across U.S., and the government and hospitals are worried
A popular medical monitor is the latest device produced in China to receive scrutiny for its potential cyber risks. However, it is not the only health device we should be concerned about. Experts say the proliferation of Chinese health-care devices in the U.S. medical system is a cause for concern across the entire ecosystem. The Contec […]
Read More
Chinese medical devices are in health systems across U.S., and the government and hospitals are worried
A popular medical monitor is the latest device produced in China to receive scrutiny for its potential cyber risks. However, it is not the only health device we should be concerned about. Experts say the proliferation of Chinese health-care devices in the U.S. medical system is a cause for concern across the entire ecosystem. The Contec […]
Read More
U.S. FDA asks fired scientists to return, including some reviewing Musk’s Neuralink
U.S. Food and Drug Administration employees reviewing Elon Musk’s brain implant company Neuralink were fired over the weekend as part of a broader purge of the federal workforce, according to two sources with knowledge of the matter. Sopa Images | Lightrocket | Getty Images The U.S. Food and Drug Administration is asking some of its […]
Read More
Sepsis a threat in pope’s pneumonia battle as Vatican Holy Year celebrations march on without him
The Vatican carried on with its Holy Year celebrations without the pope Saturday, as Pope Francis battled pneumonia and a complex respiratory infection that doctors say remains touch-and-go and will keep him hospitalized for at least another week. Francis slept well overnight, Vatican spokesman Matteo Bruni said in a brief early update Saturday. But doctors […]
Read More
Anne Wojcicki has a new offer to take 23andMe private, this time for $74.7 million
Anne Wojcicki attends the WSJ Magazine Style & Tech Dinner in Atherton, California, on March 15, 2023. Kelly Sullivan | Getty Images Entertainment | Getty Images 23andMe CEO Anne Wojcicki and New Mountain Capital have submitted a proposal to take the embattled genetic testing company private, according to a Friday filing with the U.S. Securities […]
Read More
Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker
Sopa Images | Lightrocket | Getty Images Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday, marking the end of the Bluebird’s fall from the one of the buzziest biotech firms to one that was on the cusp of running out of money. […]
Read More
Shares of Hims & Hers tumble 23% after FDA says semaglutide is no longer in shortage
Products of Hims & Hers displayed. Hims & Hers Shares of Hims & Hers Health tumbled more than 23% on Friday after the U.S. Food and Drug Administration announced that the shortage of semaglutide injection products has been resolved. Semaglutide is the active ingredient in Novo Nordisk’s blockbuster weight loss drugs Wegovy and diabetes treatment Ozempic. Those […]
Read More